BioCentury
ARTICLE | Company News

FDA accepts Zegerid capsules NDA

June 29, 2005 1:03 AM UTC

FDA accepted for filing an NDA from Santarus (SNTS) for 20 and 40 mg Zegerid omeprazole capsules to treat the symptoms of gastroesophageal reflux disease (GERD), erosive esophagitis, duodenal ulcers a...